Maria Judit Molnar

Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study

2023 | 1. lékařská fakulta

Publikace